A detailed history of Neos Investment Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 4,978 shares of MDGL stock, worth $1.55 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,978
Previous 4,598 8.26%
Holding current value
$1.55 Million
Previous $1.29 Billion 17.99%
% of portfolio
0.03%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$212.22 - $292.96 $80,643 - $111,324
380 Added 8.26%
4,978 $1.06 Billion
Q2 2024

Aug 14, 2024

SELL
$193.33 - $291.99 $190,043 - $287,026
-983 Reduced 17.61%
4,598 $1.29 Billion
Q1 2024

May 13, 2024

BUY
$171.37 - $283.23 $632,183 - $1.04 Million
3,689 Added 194.98%
5,581 $1.49 Billion
Q4 2023

Feb 13, 2024

BUY
$120.4 - $237.13 $227,796 - $448,649
1,892 New
1,892 $438 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.32B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.